You are here: Products\Immunoassays\APRIL Human ELISA:

APRIL Human ELISA

Product of BioVendor
Other names: TNF 13, Tumor necrosis factor ligand superfamily member 13 , A proliferation-inducing ligand, TNF- and APOL-related leukocyte expressed ligand 2, TNF related death ligand, CD256 antigen
Cat. No.: new product RBMS2008R Regulatory status: RUO
Size: 96 wells (1 kit) |
Files: Datasheet PDF (RUO)
Legend: new product new product
discount discount		 temporarily out of stock temporarily out of stock
book in advance order in advance

Notice

Restriction of a minimal quantity of 5 kits per order may apply.

Research topic

Apoptosis, Autoimmunity, Cytokines and chemokines and related molecules

Storage/Shipping

2–8°C

Summary

APRIL is a member of the tumor necrosis factor family. APRIL appears to play a role in T-independent type II antigen responses and T cell survival, but can also induce proliferation/sur­vival of nonlymphoid cells. Local production of APRIL was found in arthritic joints of patients with inflammatory arthritis.

Assay format

Sandwich ELISA, Biotin-labelled antibody

Sample requirements

50 µl

Applications

Cell culture supernatant, Plasma, Serum

Calibration Curve

Calibration range

0.8 – 50 ng/ml

Limit of detection

0.4 ng/ml

Limit of quantification

0.8 ng/ml

Intra-assay

CV = 8.1%

Inter-assay

CV = 7.1%

Spiking Recovery

76%

Dilution Linearity

113%

References to summary

  • Tschopp J, Ambrose C, Browning JL, Strauch K, Mullen C, Qian F, Holler N, Hertig S, Trabach L, Thompson J, Cachero TG, Schneider P, Rennert P. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med. 2000 Dec 4;192 (11):1677-84
  • Senaldi G, Hsu H, Sarosi I, Boyle WJ, Stolina M, Guo J, Xia XZ, Kornuc M, Qiu WR, McCabe S, Ramakrishnan M, Kelley M, Hawkins N, Delaney J, Boone T, Yu G, Theill LE. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol. 2000 Sep;1 (3):252-6
  • Tschopp J, Rimoldi D, Sordat B, French LE, Holler N, Bornand T, Schneider P, Bodmer JL, Irmler M, Hofmann K, Schroter M, Kataoka T, Hahne M. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med. 1998 Sep 21;188 (6):1185-90
  • Tschopp J, Hahne M, Naumann U, Klumpp A, Wagenknecht B, Roth W, Weller M. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Differ. 2001 Apr;8 (4):403-10
  • Schow P, French D, Erickson S, Tom L, Olsson C, Lawrence D, Wang H, Seshasayee D, Martin F, Kischkel F, Varfolomeev E, Grewal IS, Ashkenazi A. APRIL-deficient mice have normal immune system development. Mol Cell Biol. 2004 Feb;24 (3):997-1006
  • Jones DA, Nadauld L, Jensen G, Manos E, Kelly K. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 2000 Feb 15;60 (4):1021-7
  • Lam KP, Xu S. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol Cell Biol. 2001 Jun;21 (12):4067-74
  • Browning J, Rennert P, Schneider P, Mackay F. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2003;21:231-64
  • Albar JP, Fernandez R, Lopez-Fraga M, Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2001 Oct;2 (10):945-51
  • Hilbert DM, Nardelli B, Ullrich S, Baker KP, Stohl W, Albert V, Smith R, Hong JS, Ward CD, Sosnovtseva S, Roschke V, Migone TS. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J Immunol. 2002 Oct 15;169 (8):4314-21
  • Casali P, Schaffer A, He B, Hilbert DM, Nardelli B, Litinskiy MB, Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002 Sep;3 (9):822-9
  • Vinuesa C, MacLennan I. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity. 2002 Sep;17 (3):235-8
  • Kelley RF, Starovasnik MA, Gordon NC, Marsters SA, Shriver SK, Yin J, Wallweber HJ, Patel DR. Engineering an APRIL-specific B cell maturation antigen. J Biol Chem. 2004 Apr 16;279 (16):16727-35
  • Ashkenazi A, Dixit VM, Haas PE, Pitti RM, Yan M, Marsters SA. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol. 2000 Jun 29;10 (13):785-8
  • Hilbert DM, Migone TS, Ehresmann GR, Arkfeld DG, Perry JW, Roschke V, Xu D, Tan SM, Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003 Apr;48 (4):982-92
  • Ambrose C, Mackay F. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev. 2003 Jun-Aug;14 (3-4):311-24
  • Hardenberg G, Planelles-Carazo L, Medema JP, Hahne M. The uncertain glory of APRIL. Cell Death Differ. 2003 Oct;10 (10):1121-5

Shopping cart

Your cart is empty.